-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Apellis Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2020 to Q2 2024.
- Apellis Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.3 USD/shares, a 70.6% increase year-over-year.
- Apellis Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -2.71 USD/shares, a 53.7% increase year-over-year.
- Apellis Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -4.45 USD/shares, a 27.6% increase from 2022.
- Apellis Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -6.15 USD/shares, a 30.4% increase from 2021.
- Apellis Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -8.84 USD/shares, a 92.6% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)